| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |